MELBOURNE, Australia, Aug. 10, 2022 /PRNewswire/ -- Australian biotechnology company Starpharma today announced it has signed a new DEP^® Research Agreement with MSD, the trade name of Merck Sharp & Dohme LLC, Rahway, NJ, USA.

This new DEP^® program will generate and evaluate additional DEP^® Antibody Drug Conjugates (ADCs).

This...